Scientists Uncover Protein that Inhibits Coronaviruses

The research reveals that the LY6E protein impairs the coronavirus’ ability to initiate infection, which could lead to treatments for the illness.
Doctor holding oxygen ambu bag over patient given oxygen to patient by intubation tube in ICU/Emergency room

ACE inhibitors and Angiotensin Receptor Blockers May Increase Mortality Rate In Elderly COVID-19 Patients

These highly prescribed medications change cell surface protein expression, which is particularly problematic in cells in the respiratory system—tissue that is vulnerable to targeting and attack by the COVID-19 virus.
Source: freestylephoto/Getty Images

20 Molecular Diagnostics Companies to Watch

Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
Projections for the growth of the liquid biopsy market range as low as $1 billion by 2020

10 Liquid Biopsy Companies in the Money

10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.
Source: Martin Barraud/Getty Images

10 Countries in 100K Genome Club

These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
DNA research concept DNA barcodes for biomedical research  mitochondrial DNA  Prostate cancer DNA test

8 Companion Diagnostic Developers Making a Mark

If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
corona virus 1

Coronavirus Replication Stopped in 48 Hours in Lab-Grown Cells by Anti-Parasitic Drug

The studies showed that the drug, ivermectin, started to become effective against SARS-CoV-2 in lab-grown cells within just a day and “could essentially remove all viral RNA by 48 hours,” researchers said.
Ominous blue coronavirus cells intertwined with DNA and white blood cells on dark

Italian Researchers Identify Common Susceptibility Genes in COVID-19 Patients

The researchers looked to identify genetic differences with clinical outcomes. Using that study form, for each patient, the team identified an average of three disease-causing mutations involved in COVID-19 susceptibility.

Abbott Launching ID NOW COVID-19 Tests, Offering Positive Results in Five Minutes

Company expects to deliver 50,000 tests per day of the rapid, instrument-based, isothermal system designed for qualitative detection of infectious diseases.
Potential coronavirus drugs, illustration

Four Promising Antiviral Drug Candidates Identified to Fight COVID-19

The researchers, based at University of South Florida Health and the University of Arizona College of Pharmacy, worked together to screen 55 possible antiviral compounds to assess their ability to treat SARS-CoV-2.
Scroll Up